Pantheon International PLC Appointment of Non-Executive Director

RNS Number : 4847V

Pantheon International PLC

31 January 2025

 

31 January 2025

 

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc

("PIP" or the "Company")

 

Appointment of Non-Executive Director

 

The Board of PIP is pleased to announce the appointment of Candida Morley as Non-Executive Director of the Company and a member of the Audit, Management Engagement and Nomination Committees with effect from 31 January 2025.

Candida Morley is a seasoned private equity, strategy and operations professional with over 34 years of executive experience. This included senior roles at private equity firms HgCapital and LDC, as well as earlier experience at 3i PLC and in strategy at a FTSE 250 plc. She also has an extensive track record at senior board level, having worked as part of around 20 boards to promote shared strategic direction and focused value creation, and has represented the British Private Equity and Venture Capital Association (BVCA) as part of the Wates Corporate Governance Principles framework. Candida is currently the Senior Independent Director of the Scottish National Investment Bank and until November 2024 was a Director of UK Government Investments (UKGI).

There are no other details or disclosures to be made which are required under LR 6.4.8R of the Financial Conduct Authority's Listing Rules for the appointment of Candida Morley.

John Singer CBE, Chair of PIP, commented: "I am delighted that Candida has agreed to join the Board of PIP. This is an exciting time for PIP, as we implement our three-step shareholder-focused corporate strategy, and Candida's deep private equity, corporate finance and strategic expertise will further enhance the extensive skills and knowledge on PIP's high quality, diverse Board."

Ends

 

LEI: 2138001B3CE5S5PEE928

 

For more information please visit PIP's website at www.piplc.com or contact:

 

Pantheon

Helen Steers / Charlotte Morris / Vicki Bradley

Tel: [phone]

Follow us on LinkedIn: https://www.linkedin.com/company/pantheon-international-plc

NOTES

 

PIP

PIP is a listed FTSE 250 private equity investment trust, overseen by an independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investors a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of some of the best managers in the world. The Company has a track record of NAV outperformance over the long term and manages risk strategically through diversification and rigorous selection based on Pantheon's extensive experience and international platform, and robust investment due diligence and decision-making processes.

 

Pantheon

PIP is managed and advised by Pantheon, a specialist global private markets investor. Pantheon has been at the forefront of private markets investing for more than 40 years, earning a reputation for providing innovative solutions covering the full lifecycle of investments, across private equity, real assets and private credit. The firm has partnered with more than 680 clients, with approximately $68bn in discretionary assets under management (as at 30 June 2024).

 

Important Information

A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAFLFLLLFILVIE